Neuroprotective Effects of Encapsulated CNTF-Producing Cells in a Rodent Model of Huntington's Disease Are Dependent on the Proximity of the Implant to the Lesioned Striatum

Cell Transplantation

Volumn 13, Issue 3, 2004, Pages 253-259

  Ernerich, Dwaine F ^a,c   Winnt, Shelley R ^b  

^a LCT BioPharma   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

CNTF; Fibroblasts; Gene therapy; Huntington's disease; Neurotrophic factors; Polymer encapsulation; Quinolinic acid

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CILIARY NEUROTROPHIC FACTOR; GLUTAMATE DECARBOXYLASE; QUINOLINIC ACID;

AKINESIA; ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL BASED GENE THERAPY; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUNTINGTON CHOREA; LATERAL BRAIN VENTRICLE; MALE; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALIA; RODENTIA;

EID: 2442529846     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000004783983981     Document Type: Article

References (45)

1. Aebischer, P.; Schleup, M.; Deglon, N.; Joseph, J.-M.; Hirt, L.; Heyd, B.; Goddard, M.; Hammang, J. P.; Zurn, A. D.; Kato, A. C.; Regli, F.; Baetge, E. E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2: 696-699; 1996.
2. Bachoud-Levi, A. C.; Deglon, N.; Nguyen, J.-P.; Bloch, J.; Bourdet, C.; Winkel, L.; Remy, P.; Goddard, M.; Lefaucher, J. P.; Brugieres, P.; Baudic, S.; Cesaro, P.; Peschanski, M.; Aebischer, P. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum. Gene Ther. 11:1723-1729; 2000.
3. Barkats, M.; Bilang-Bleuel, A.; Buc-Caron, M. H.; Castel-Barthe, M. N.; Corti, O.; Finiels, F.; Horellou, P.; Revah, F.; Sabate, O.; Mallet, J. Adenovirus in the brain: Recent advances of gene therapy for neuro degenerative diseases. Prog. Neurobiol. 55:333-341; 1998.
4. Borlongan, C. V.; Emerich, D. F.; Hoffer, B. J.; Bartus, R. T. Bradykinin receptor agonist facilitates low dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity. Brain Res. 956:211-220; 2002.
5. Borlongan, C. V.; Emerich, D. F. Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: Laboratory and preliminary evidence from the bradykinin receptor agonist Cereport. Brain Res. Bull. 60:297-306; 2003.
6. Borlongan, C. V.; Hess, D. C. G-CSF-mobilized human peripheral blood for transplantation therapy in stroke. Cell Transplant. 12:447-448; 2003.
7. Bowers, W.; Howard, D.; Federoff, H. Gene therapeutic strategies for neuroprotection: Implications for Parkinson's disease. Exp. Neurol. 144:58-68; 1997.
8. deAlmeida, L. P.; Zala, D.; Aebischer, P.; Deglon, N. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease. Neurobiol. Dis. 8:433-446; 2001.
9. Dunnett, S. B.; Björklund, A. Functional neural transplantation. New York: Raven Press; 1994.
10. Emerich, D. F.; Winn, S. R.; Lindner, M. D.; Frydel, B. R.; Kordower, J. H. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J. Neurosci. 16:5168-5181; 1996.
11. Emerich, D. F.; Cain, C. K.; Greco, C.; Saydoff, J. A.; Hu, Z-Y.; Liu, H.; Lindner, M. D. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease. Cell Transplant. 6:249-266; 1997.
12. Emerich, D. F.; Winn, S. R.; Chen, E-Y.; Chu, Y.; McDermott, P.; Baetge, E.; Kordower, J. H. Protection of basal ganglia circuitry by encapsulated CNTF-producing cells in a primate model of Huntington's disease. Nature 386:395-399; 1997.
13. Emerich, D. F.; Salzberg, H. Update on cell encapsulation for neurodegenerative CNS diseases. Cell Transplant. 10:3-24; 2001.
14. Englund, U.; Björklund, A.; Wictorin, K. Migration patterns and phenotypic differentiation of long-term expanded human neural progenitor cells after transplantation into the adult rat brain. Brain Res. Dev. Brain Res. 134:123-141; 2002.
15. Freed, W. J.; Poltorak, M.; Becker, J. B. Intracerebral adrenal medulla grafts: A review. Exp. Neurol. 110:139-166; 1990.
16. Friden, P. M.; Walus, L. R.; Watson, P.; Doctrow, S. R.; Kozarich, J. W. ; Backman, C.; Bergman, H.; Hoffer, B.; Bloom, F.; Granholm, A. C. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259:373-377; 1993.
17. Friden, P. M. Receptor-mediated transport of therapeutics across the blood-brain barrier. Neurosurgery 35:294-298; 1994.
18. Garbuzova-Davis, S.; Willing, A. E.; Zigova, T.; Saporta, S.; Justen, E. B.; Lane, J. C.; Hudson, J. E.; Chen, N.; Davis, C. D.; Sanberg, P. R. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: Distribution, migration, and differentiation. J. Hematother. Stem Cell Res. 12:255-270; 2003.
19. Hoffman, D.; Wahlberg, L.; Aebischer, P. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp. Neurol. 110:39-44; 1990.
20. 125I] glial cell line-derived neurotrophic factor to the rat CNS following osmotic blood-brain barrier modification. Neurosci. Lett. 220: 187-190; 1996.
21. Kaplitt, M.; Darakchiev, B.; During, M. Prospects for gene therapy in pediatric neurosurgery. Pediatr. Neurosurg. 28:3-14; 1998.
22. Kordower, J. H.; Mufson, E. J.; Granholm, A. C.; Hoffer, B.; Friden, P. Delivery of trophic factors to the primate brain. Exp. Neurol. 124:21-30; 1993.
23. Kordower, J. H.; Isacson, O.; Emerich, D. F. Cellular delivery of trophic factors for the treatment of Huntington's disease: Is neuroprotection possible? Exp. Neurol. 159:4-20; 1999.
24. Kordower, J. K. In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease. Ann. Neurol. 53:120-132; 2003.
25. Kroll, R. A.; Neuwelt, E. A. Outwitting the blood-brain barrier for therapeutic purposes: Osmotic opening and other means. Neurosurgery 42:1083-1099; 1998.
26. Langer, R.; Moses, M. Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J. Cell. Biochem. 45:340-345; 1991.
27. Mittoux, V.; Joseph, J. M.; Conde, F.; Palfi, S.; Dautry, C.; Poyot, T.; Bloch, J.; Deglon, N.; Ouary, S.; Nimchinsky, E. A.; Brouillet, E.; Hof, P. R.; Peschanski, M.; Aebischer, P.; Hantraye, P. Restoration of cognitive and motor function with ciliary neurotrophic factor in a primate model of Huntington's disease. Hum. Gene Ther. 11:1177-1187; 2000.
28. Mittoux, V.; Quary, S.; Monville, C.; Lisovoski, F.; Poyot, T.; Conde, F.; Escartin, C.; Robischon, R.; Brouillet, E.; Peschanski, M.; Hantraye, P. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration. J. Neurosci. 22:4478-4486; 2002.
29. Mufson, E. J.; Kroin, J. S.; Sendera, T. J.; Sobreviela, T. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57:451-484; 1999.
30. Olanow, C. W.; Goetz, C. G.; Kordower, J. H.; Stoessl, A. J.; Brin, M. F.; Shannon, K. M.; Nauert, G. M.; Perl, D. P.; Godbold, J.; Freeman, T. B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54:403-414; 2003.
31. Olson, L.; Backlund, E. O.; Ebendal, T.; Freedman, R.; Hamberger, B.; Hansson, P.; Hoffer, B.; Lindblom, U.; Meyerson, B.; Stromberg, I. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch. Neurol. 48:373-381; 1991.
32. Penney, J. B.; Young, A. B.; Shoulson, I. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Movement Disord. 5:93-99; 1990.
33. Regulier, E.; Perreira de Almeida, L.; Sommer, B.; Aebischer, P.; Deglon, N. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum. Gene Ther. 13:1981-1990; 2002.
34. Riddle, D. R.; Katz, L. C.; Lo, D. C. Focal delivery of neurotrophins into the central nervous system using fluorescent latex microspheres. Biotechniques 23:928-937; 1997.
35. Saporta, S.; Kim, J. J.; Willing, A. E.; Fu, E. S.; Davis, C. D.; Sanberg, P. R. Human umbilical cord blood stem cell infusion in spinal cord injury: Engraftment and beneficial influence on behavior. J. Hematother. Stem Cell Res. 12:271-278; 2003.
36. Shoichet, M. S.; Winn, S. R. Cell delivery to the central nervous system. Adv. Drug Deliv. Rev. 20:81-102; 2000.
37. Shoulson, I. Huntington's disease: Functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 31:1333-1335; 1981.
38. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-978; 1993.
39. Vahlsing, H. L.; Varon, S.; Hagg, T.; Fass-Holmes, B.; Dekker, A.; Mamley, M.; Mansthorpe, M. An improved device for continuous intraventricular infusions prevents the introduction of pump-derived toxins and increases the effectiveness of NGF treatments. Exp. Neurol. 105:233-243; 1989.
40. Willing, A. E.; Vendrame, M.; Mallery, J.; Cassady, C. J.; Davis, C. D. Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant. 12:449-454; 2003.
41. Willing, A. E.; Lixian, J.; Milliken, M.; Poulos, S.; Zigova, T.; Song, S.; Hart, C. D.; Sanchez-Ramos, J.; Sanberg, P. R. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 73:296-307; 2003.
42. Winn, S. R.; Wahlberg, L.; Tresco, P. A.; Aebischer, P. An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats. Exp. Neurol. 105:244-250; 1989.
43. Yurek, D. M.; Sladek, J. R. Dopamine cell replacement: Parkinson's disease. Ann. Rev. Neurosci. 13:415-440; 1990.
44. Zhang, R. L.; Zhang, L.; Zhang, Z. G.; Morris, D.; Jiang, Q.; Wang, L.; Zhang, L. J.; Chopp, M. Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into the adult rat striatum. Neuroscience 116:373-382; 2003.
45. Zlokovic, B. V.; Apuzzo, M. L. J. Cellular and molecular neurosurgery: Part II: Vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery 40:805-812; 1997.